Product Pipeline

Oncology

• CAL-101 Hematololgic malignancies
• CAL-120 Solid tumor malignancies

Inflammation

• CAL-263 Asthma, rheumatoid arthritis,
  inflammatory diseases

Research

• Isoform-Selective PI3K Inhibitors
  Follow-on compounds and
  other therapeutic opportunities